Global Hospital-Acquired Disease Testing Market 2019 - Qiagen, F. Hoffmann-La Roche, Cepheid

Hospital acquired infections/diseases (HAIs) or nosocomial infections are defined to the infection acquired by patients during their stay in healthcare settings. Approximately 9.2 out of 100 patients in the U.S. acquire HAI. The most common types of HAIs include pneumonia, urinary tract infection, bloodstream infection, surgical site infection and others. HAIs are caused by pathogens among patients with compromised immune system, and negligence by hospital staff. The significant morbidity and mortality, the associated management costs and growing pressure from governing bodies have urged care-givers to devise accurate diagnosis of HAIs for efficient healthcare provision.

Get Free Sample Copy of Report Here: https://bit.ly/2RqXgzh

Scope of the Report:
This report studies the Hospital-Acquired Disease Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Hospital-Acquired Disease Testing market by product type and applications/end industries.
The increasing incidence of hospital acquired infections (HAI) is one of the key factors propelling the global hospital acquired disease testing market. For the prevention of these infections many countries such as the U.S. have issued rules and regulations to be mounted in the hospitals and clinics. For instance, the U.S. has regulated HHS Action Plan to reduce infections auqired in hospitals. These government plans and movements and increasing investments are expected to poise to growth of the global market of hospital acquired disease testing. Furthermore, the rising number of pathogens with drug-resistant abilities is foreseen to help the market expand. Numerous hospitals around the world are facilitating the pathogen detection procedures with improved surveillance culture. To prevent the transmission of diseases, various health organizations are demanding for effective hospital acquired disease testing solutions.
The majority of regulations regarding molecular-biology-based diagnostics remain un-updated, which can act as a restraining factor. Furthermore, the absence of control authorities and efficient control programs in less developed countries could hinder the market growth. For instance, African countries such as Nigeria do not have any effective programs or authority to prevent or control hospital acquired diseases.
North America has the largest share in this market followed by Europe. Due to the increase in medical tourism industry in Asian countries, the Asia-Pacific market is expected to flourish in the forecasted period.
The global Hospital-Acquired Disease Testing market is valued at 520 million USD in 2017 and is expected to reach 700 million USD by the end of 2023, growing at a CAGR of 5.1% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Hospital-Acquired Disease Testing.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Inquire Before Buying @ https://bit.ly/2SNR8hi

Market Segment by Companies, this report covers
Diatherix Laboratories
Gen-Probe
Qiagen
F. Hoffmann-La Roche
Cepheid
Life Technologies Corporation
Meridian Biosciences
Cantel Medical Corporation
Nordion

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
UTI Testing
SSI Testing
Pneumococcal Infections Testing
Bloodstream Infections Testing
MRSA Testing

Market Segment by Applications, can be divided into
Small and Medium Sized Hospitals
Large Sized Hospitals

About Us

“Apex Market Reports” offers elevating market research globally. We have collection of various syndicated reports of different categories. “Apex Market Reports” provides you to best services, weather you’re searching for new trends in market or competitive scenario in emerging market.
Customers can buys different reports across various categories such as Chemical and Material, Biotechnology, Healthcare, Food and beverages, Automobile and various sectors. Our Website offers safe and secure online ordering experience, convenient payment options.

Contact Us

Frank Valadez
S no. 72/1/A/6, Floor No. 1,
Harikrishna Building, Samarth Nagar,
New Sanghvi, Pune-411027 India.
Phone: +91-8149441100
Email id - sales@apexmarketreports.com
Website - www.apexmarketreports.com

This release was published on openPR.